CF
38
-3
DNB
36
2
AMGN
47
-13
HIG
72
-2
PEG
41
-3
SLG
71
-4
PNW
49
4
GPS
57
-3
PM
52
-4
BBY
55
-2
C
37
-2
SIG
47
-3
DE
29
-3
AEE
46
11
ADM
36
2
GWW
46
2
CNP
65
-3
WRK
60
-3
AVY
74
2
PDCO
57
2
CF
38
-3
DNB
36
2
AMGN
47
-13
HIG
72
-2
PEG
41
-3
SLG
71
-4
PNW
49
4
GPS
57
-3
PM
52
-4
BBY
55
-2
C
37
-2
SIG
47
-3
DE
29
-3
AEE
46
11
ADM
36
2
GWW
46
2
CNP
65
-3
WRK
60
-3
AVY
74
2
PDCO
57
2
Financhill
Back

Novo Nordisk A/S Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
71

NONOF
Novo Nordisk A/S

Last Price:
138.76
Seasonality Move:
6.93%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
71
Novo Nordisk A/S (NONOF) is a Buy

Is Novo Nordisk A/S a Buy, Sell or Hold?

  • The current Novo Nordisk A/S [NONOF] share price is $138.76. The Score for NONOF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • NONOF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NONOF Stock Price Chart

What is Novo Nordisk A/S's stock price today?

  • The Novo Nordisk A/S share price today is $138.76
    The current trend is moderately bearish and NONOF is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.14 Buy
Relative Strength Index (14 RSI): 50.83 Buy
Chaikin Money Flow: -332770 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (133.98 - 143) Buy
Bollinger Bands (100): (120.92 - 136.08) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.68 Sell
20-day SMA: 139.74 Sell
50-day SMA: 132.22 Buy
200-day SMA: 113.91 Buy
8-day EMA: 142.28 Sell
20-day EMA: 139.75 Sell
50-day EMA: 134.31 Buy
200-day EMA: 116.06 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Novo Nordisk A/S Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):